CAS: 252930-37-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ATPO REF: IN-DA00BITSCAS: 252930-37-3 | 95% | To inquire | Tue 10 Dec 24 |
 | ATPO REF: 7W-GL9891CAS: 252930-37-3 | - - - | To inquire | Tue 10 Dec 24 |
 | (S)-ATPO REF: TM-T3473CAS: 252930-37-3 | 98.37% - 99.41% | 52.00 €~639.00 € | Mon 16 Dec 24 |
 | ATPO REF: 3D-CKA93037CAS: 252930-37-3 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA00BITS
| 25mg | 509.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
(S)-ATPO
CAS:252930-37-3
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
Formula:
C11H19N2O7P
Purity:
98.37% - 99.41%
Color and Shape:
Solid
Molecular weight:
322.25
Ref: TM-T3473
| 1mg | 52.00 € | ||
| 2mg | 73.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 280.00 € | ||
| 50mg | 438.00 € | ||
| 100mg | 639.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
ATPO
CAS:252930-37-3
Atovaquone is a medication used to treat chronic viral hepatitis and other conditions. It inhibits …
Formula:
C11H19N2O7P
Purity:
Min. 95%
Molecular weight:
322.25 g/mol
Ref: 3D-CKA93037
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
